niclosamide has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kang, HW | 1 |
Kim, JH | 1 |
Lee, DE | 1 |
Lee, YS | 1 |
Kim, MJ | 1 |
Kim, HS | 1 |
Fang, S | 1 |
Lee, BE | 1 |
Lee, KJ | 1 |
Yoo, J | 1 |
Kim, HJ | 1 |
Park, JS | 1 |
1 other study available for niclosamide and Carcinoma, Pancreatic Ductal
Article | Year |
---|---|
Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer.
Topics: Apoptosis; beta Catenin; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Gemcita | 2023 |